These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 8613969

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Differential inhibition of thrombin activity and thrombin generation by a synthetic direct thrombin inhibitor (napsagatran, Ro 46-6240) and unfractionated heparin in patients with deep vein thrombosis. ADVENT Investigators.
    Bounameaux H, Ehringer H, Gast A, Hulting J, Rasche H, Rapold HJ, Reber G, Tschopp TB.
    Thromb Haemost; 1999 Apr; 81(4):498-501. PubMed ID: 10235427
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dissociation of antithrombotic effect and bleeding time prolongation in rabbits by inhibiting tissue factor function.
    Himber J, Kirchhofer D, Riederer M, Tschopp TB, Steiner B, Roux SP.
    Thromb Haemost; 1997 Sep; 78(3):1142-9. PubMed ID: 9308768
    [Abstract] [Full Text] [Related]

  • 9. A novel synthetic inhibitor of factor Xa decreases early reocclusion and improves 24-h patency after coronary fibrinolysis in dogs.
    Abendschein DR, Baum PK, Verhallen P, Eisenberg PR, Sullivan ME, Light DR.
    J Pharmacol Exp Ther; 2001 Feb; 296(2):567-72. PubMed ID: 11160645
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological profile of recombinant, human activated protein C (LY203638) in a canine model of coronary artery thrombosis.
    Jackson CV, Bailey BD, Shetler TJ.
    J Pharmacol Exp Ther; 2000 Dec; 295(3):967-71. PubMed ID: 11082430
    [Abstract] [Full Text] [Related]

  • 11. Primary prevention of coronary arterial thrombosis with the factor Xa inhibitor rTAP in a canine electrolytic injury model.
    Lynch JJ, Sitko GR, Lehman ED, Vlasuk GP.
    Thromb Haemost; 1995 Aug; 74(2):640-5. PubMed ID: 8585000
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M, Golino P, Cirillo P, Pascucci I, Scognamiglio A, Ravera A, Esposito N, Battaglia C, Guarino A, Chiariello M.
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of PAI-039 [{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid], a novel plasminogen activator inhibitor-1 inhibitor, in a canine model of coronary artery thrombosis.
    Hennan JK, Elokdah H, Leal M, Ji A, Friedrichs GS, Morgan GA, Swillo RE, Antrilli TM, Hreha A, Crandall DL.
    J Pharmacol Exp Ther; 2005 Aug; 314(2):710-6. PubMed ID: 15860572
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of thrombus formation by endothelin-1 in canine models of arterial thrombosis.
    Leadley RJ, Humphrey WR, Erickson LA, Shebuski RJ.
    Thromb Haemost; 1995 Dec; 74(6):1583-90. PubMed ID: 8772241
    [Abstract] [Full Text] [Related]

  • 17. Antithrombotic and bleeding effects of a new synthetic direct thrombin inhibitor and of standard heparin in the rabbit.
    Cadroy Y, Caranobe C, Bernat A, Maffrand JP, Sié P, Boneu B.
    Thromb Haemost; 1987 Aug 04; 58(2):764-7. PubMed ID: 3672429
    [Abstract] [Full Text] [Related]

  • 18. Activated clotting time as an appropriate test to compare heparin and direct thrombin inhibitors such as hirudin or Ro 46-6240 in experimental arterial thrombosis.
    Carteaux JP, Gast A, Tschopp TB, Roux S.
    Circulation; 1995 Mar 01; 91(5):1568-74. PubMed ID: 7867200
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis.
    Kaiser B, Fareed J.
    Thromb Haemost; 1996 Oct 01; 76(4):615-20. PubMed ID: 8903005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.